This study demonstrated extensive brain white matter alterations in pediatric SMA types 2 and 3, which is responsive to the effects of SMN protein deficit on brain white matter since individuals with SMA types 2 and 3 are less likely to be affected by ischemic-hypoxic encephalopathy [13]. The gene discussed is SMN1; the disease is proximal spinal muscular atrophy.